<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37898798</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1479-5876</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>28</Day></PubDate></JournalIssue><Title>Journal of translational medicine</Title><ISOAbbreviation>J Transl Med</ISOAbbreviation></Journal><ArticleTitle>Evaluation of viral infection as an etiology of ME/CFS: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>763</StartPage><MedlinePgn>763</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">763</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12967-023-04635-0</ELocationID><Abstract><AbstractText Label="BACKGROUND">Myalgic encephalitis/chronic fatigue syndrome (ME/CFS) is a long-term disabling illness without a medically explained cause. Recently during COVID-19 pandemic, many studies have confirmed the symptoms similar to ME/CFS in the recovered individuals. To investigate the virus-related etiopathogenesis of ME/CFS, we conducted a systematic assessment of viral infection frequency in ME/CFS patients.</AbstractText><AbstractText Label="METHODS">We conducted a comprehensive search of PubMed and the Cochrane Library from their inception through December 31, 2022, using selection criteria of viral infection prevalence in ME/CFS patients and controls. Subsequently, we performed a meta-analysis to assess the extent of viral infections' contribution to ME/CFS by comparing the odds ratio between ME/CFS patients and controls (healthy and/or diseased).</AbstractText><AbstractText Label="RESULTS">Finally, 64 studies met our eligibility criteria regarding 18 species of viruses, including a total of 4971 ME/CFS patients and 9221 control subjects. The participants included healthy subjects and individuals with one of 10 diseases, such as multiple sclerosis or fibromyalgia. Two DNA viruses (human herpes virus (HHV)-7 and parvovirus B19, including their co-infection) and 3 RNA viruses (borna disease virus (BDV), enterovirus and coxsackie B virus) showed odds ratios greater than 2.0 compared with healthy and/or diseased subjects. Specifically, BDV exceeded the cutoff with an odds ratio of ≥ 3.47 (indicating a "moderate association" by Cohen's d test) compared to both healthy and diseased controls.</AbstractText><AbstractText Label="CONCLUSION">This study comprehensively evaluated the risk of viral infections associated with ME/CFS, and identified BDV. These results provide valuable reference data for future studies investigating the role of viruses in the causation of ME/CFS.</AbstractText><CopyrightInformation>© 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Jae-Hyun</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Korean Medical College of Daejeon University, 62, Daehak-Ro, Dong-Gu, Daejeon, Republic of Korea, 34520.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jin-Seok</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Institute of Bioscience and Integrative Medicine, Daejeon University, 62 Daehak-Ro, Dong-Gu, Daejeon, Republic of Korea, 34520.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Hyeon-Muk</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Institute of Bioscience and Integrative Medicine, Daejeon University, 62 Daehak-Ro, Dong-Gu, Daejeon, Republic of Korea, 34520.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Eun-Jung</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Korean Rehabilitation Medicine, College of Korean Medicine, Daejeon University, 176 Daedeok-Daero, Seo-Gu, Daejeon, Republic of Korea, 35235.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Eun-Jin</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Integrative Medicine, Graduate School of Integrative Medicine, CHA University, 335 Pangyo-Ro, Bundang-Gu, Seongnam-city, 13488, Gyeonggi-Do, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Son</LastName><ForeName>Chang-Gue</ForeName><Initials>CG</Initials><Identifier Source="ORCID">0000-0003-4876-0167</Identifier><AffiliationInfo><Affiliation>Institute of Bioscience and Integrative Medicine, Daejeon University, 62 Daehak-Ro, Dong-Gu, Daejeon, Republic of Korea, 34520. ckson@dju.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for CFS/ME, Daejeon Oriental Hospital of Daejeon University, 176 Daedeok-Daero, Seo-Gu, Daejeon, Republic of Korea, 35235. ckson@dju.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Transl Med</MedlineTA><NlmUniqueID>101190741</NlmUniqueID><ISSNLinking>1479-5876</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004660" MajorTopicYN="Y">Encephalitis</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005356" MajorTopicYN="N">Fibromyalgia</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chronic fatigue syndrome (CFS)</Keyword><Keyword MajorTopicYN="N">Disease causation</Keyword><Keyword MajorTopicYN="N">Etiopathogenesis</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Myalgic encephalitis (ME)</Keyword><Keyword MajorTopicYN="N">Odds ratio</Keyword><Keyword MajorTopicYN="N">Viral infection</Keyword></KeywordList><CoiStatement>There are no potential competing interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>29</Day><Hour>0</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37898798</ArticleId><ArticleId IdType="pmc">PMC10612276</ArticleId><ArticleId IdType="doi">10.1186/s12967-023-04635-0</ArticleId><ArticleId IdType="pii">10.1186/s12967-023-04635-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A, Group ICFSS The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med. 1994;121(12):953–959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton EW. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness. JAMA. 2015;313(11):1101–1102. doi: 10.1001/jama.2015.1346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.1346</ArticleId><ArticleId IdType="pubmed">25668027</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E-J, Ahn Y-C, Jang E-S, Lee S-W, Lee S-H, Son C-G. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) J Transl Med. 2020;18(1):1–15. doi: 10.1186/s12967-020-02269-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02269-0</ArticleId><ArticleId IdType="pmc">PMC7038594</ArticleId><ArticleId IdType="pubmed">32093722</ArticleId></ArticleIdList></Reference><Reference><Citation>Bested AC, Marshall LM. Review of myalgic encephalomyelitis/chronic fatigue syndrome: an evidence-based approach to diagnosis and management by clinicians. Rev Environ Health. 2015;30(4):223–249. doi: 10.1515/reveh-2015-0026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/reveh-2015-0026</ArticleId><ArticleId IdType="pubmed">26613325</ArticleId></ArticleIdList></Reference><Reference><Citation>Bethesda M. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) research: workshop report. State of the knowledge workshop. National Institutes of Health. 2011; 2019.</Citation></Reference><Reference><Citation>McManimen SL, Devendorf AR, Brown AA, Moore BC, Moore JH, Jason LA. Mortality in patients with myalgic encephalomyelitis and chronic fatigue syndrome. Fatigue Biomed Health Behav. 2016;4:195. doi: 10.1080/21641846.2016.1236588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2016.1236588</ArticleId><ArticleId IdType="pmc">PMC5218818</ArticleId><ArticleId IdType="pubmed">28070451</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiménez Ortiz JJ. Depresión y desesperanza en personas enfermas de Encefalomielitis Miálgica/Síndrome de Fatiga Crónica: factores de riesgo y de protección. 2015.</Citation></Reference><Reference><Citation>Baker R, Shaw E. Diagnosis and management of chronic fatigue syndrome or myalgic encephalomyelitis (or encephalopathy): summary of NICE guidance. BMJ. 2007;335(7617):446–448. doi: 10.1136/bmj.39302.509005.AE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39302.509005.AE</ArticleId><ArticleId IdType="pmc">PMC1962830</ArticleId><ArticleId IdType="pubmed">17762037</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeves WC, Lloyd A, Vernon SD, Klimas N, Jason LA, Bleijenberg G, Evengard B, White PD, Nisenbaum R, Unger ER. Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res. 2003;3(1):1–9. doi: 10.1186/1472-6963-3-25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6963-3-25</ArticleId><ArticleId IdType="pmc">PMC317472</ArticleId><ArticleId IdType="pubmed">14702202</ArticleId></ArticleIdList></Reference><Reference><Citation>Unger ER, Lin JMS, Brimmer DJ, Lapp CW, Komaroff AL, Nath A, Laird S, Iskander J. CDC grand rounds: chronic fatigue syndrome—advancing research and clinical education. Morbid Mortal Wkly Rep. 2016;65(50 &amp; 51):1434–1438. doi: 10.15585/mmwr.mm655051a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm655051a4</ArticleId><ArticleId IdType="pubmed">28033311</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya JG, Holmes TH, Anderson JN, Maecker HT, Rosenberg-Hasson Y, Valencia IJ, Chu L, Younger JW, Tato CM, Davis MM. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc Natl Acad Sci. 2017;114(34):E7150–E7158. doi: 10.1073/pnas.1710519114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1710519114</ArticleId><ArticleId IdType="pmc">PMC5576836</ArticleId><ArticleId IdType="pubmed">28760971</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleare AJ. The HPA axis and the genesis of chronic fatigue syndrome. Trends Endocrinol Metab. 2004;15(2):55–59. doi: 10.1016/j.tem.2003.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2003.12.002</ArticleId><ArticleId IdType="pubmed">15036250</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawley E. The epidemiology of chronic fatigue syndrome/myalgic encephalitis in children. Arch Dis Child. 2014;99(2):171–174. doi: 10.1136/archdischild-2012-302156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2012-302156</ArticleId><ArticleId IdType="pubmed">24146285</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L, Bested AC, Bonilla HF, Chheda BV, Chu L, Curtin JM, Dempsey TT, Dimmock ME, Dowell TG, Felsenstein D. Myalgic encephalomyelitis/chronic fatigue syndrome: essentials of diagnosis and management. In: Mayo Clinic Proceedings: 2021: Elsevier; 2021: 2861–2878.</Citation><ArticleIdList><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth KJ, Scheibenbogen C. Pathophysiology of skeletal muscle disturbances in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J Transl Med. 2021;19(1):1–16. doi: 10.1186/s12967-021-02833-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02833-2</ArticleId><ArticleId IdType="pmc">PMC8058748</ArticleId><ArticleId IdType="pubmed">33882940</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey R, DeMars J, Franklin K, Culos-Reed SN, Weatherald J, Wrightson JG. Chronic fatigue and postexertional malaise in people living with long COVID: an observational study. Phys Ther. 2022;102(4):pzac005. doi: 10.1093/ptj/pzac005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzac005</ArticleId><ArticleId IdType="pmc">PMC9383197</ArticleId><ArticleId IdType="pubmed">35079817</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Dorri JA. ME/CFS and post-exertional malaise among patients with long COVID. Neurol Int. 2022;15(1):1–11. doi: 10.3390/neurolint15010001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint15010001</ArticleId><ArticleId IdType="pmc">PMC9844405</ArticleId><ArticleId IdType="pubmed">36648965</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, Redfield S, Austin JP, Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin R, Riste L, Hann M, Walther A, Mukherjee A, Heald A. Into the looking glass: post-viral syndrome post COVID-19. Med Hypotheses. 2020;144:110055. doi: 10.1016/j.mehy.2020.110055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110055</ArticleId><ArticleId IdType="pmc">PMC7320866</ArticleId><ArticleId IdType="pubmed">32758891</ArticleId></ArticleIdList></Reference><Reference><Citation>Jelinek J. Benign encephalomyelitis. Lancet. 1956;268:494–495. doi: 10.1016/S0140-6736(56)91974-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(56)91974-2</ArticleId><ArticleId IdType="pubmed">13368438</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobi M, Ravid Z, Feldman-Weiss V, Ben-Chetrit E, Morag A, Chowers I, Michaeli Y, Shalit M, Knobler H. Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. The Lancet. 1982;319(8263):61–64. doi: 10.1016/S0140-6736(82)90210-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(82)90210-0</ArticleId><ArticleId IdType="pubmed">6119490</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605. doi: 10.1007/s10654-010-9491-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-010-9491-z</ArticleId><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Smith GD. Meta-analysis bias in location and selection of studies. BMJ. 1998;316(7124):61–66. doi: 10.1136/bmj.316.7124.61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.316.7124.61</ArticleId><ArticleId IdType="pmc">PMC2665334</ArticleId><ArticleId IdType="pubmed">9451274</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T, Scheibenbogen C, Murovska M, Prusty BK. ME/CFS ENo: Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J Transl Med. 2018;16:1–25. doi: 10.1186/s12967-018-1644-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal A, Bradley A, Bishop K, Kiani-Alikhan S, Ford B. Chronic fatigue syndrome, the immune system and viral infection. Brain Behav Immun. 2012;26(1):24–31. doi: 10.1016/j.bbi.2011.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2011.06.016</ArticleId><ArticleId IdType="pubmed">21756995</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe PC, Underhill RA, Friedman KJ, Gurwitt A, Medow MS, Schwartz MS, Speight N, Stewart JM, Vallings R, Rowe KS. Myalgic encephalomyelitis/chronic fatigue syndrome diagnosis and management in young people: a primer. Front Pediatr. 2017;5:121. doi: 10.3389/fped.2017.00121.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2017.00121</ArticleId><ArticleId IdType="pmc">PMC5474682</ArticleId><ArticleId IdType="pubmed">28674681</ArticleId></ArticleIdList></Reference><Reference><Citation>Navaneetharaja N, Griffiths V, Wileman T, Carding SR. A role for the intestinal microbiota and virome in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)? J Clin Med. 2016;5(6):55. doi: 10.3390/jcm5060055.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm5060055</ArticleId><ArticleId IdType="pmc">PMC4929410</ArticleId><ArticleId IdType="pubmed">27275835</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science. 2009;326(5952):585–589. doi: 10.1126/science.1179052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1179052</ArticleId><ArticleId IdType="pubmed">19815723</ArticleId></ArticleIdList></Reference><Reference><Citation>Mozhgani S-H, Rajabi F, Qurbani M, Erfani Y, Yaslianifard S, Moosavi A, Pourrostami K, Baradaran Bagheri A, Soleimani A, Behzadian F. Human herpesvirus 6 infection and risk of chronic fatigue syndrome: a systematic review and meta-analysis. Intervirology. 2022;65(1):49–57. doi: 10.1159/000517930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000517930</ArticleId><ArticleId IdType="pmc">PMC8820437</ArticleId><ArticleId IdType="pubmed">34348314</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)—a systemic review and comparison of clinical presentation and symptomatology. Medicina. 2021;57(5):418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal R, Gubbi S, Koch CA. COVID-19 and chronic fatigue syndrome: an endocrine perspective. J Clin Transl Endocrinol. 2022;27:100284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8641402</ArticleId><ArticleId IdType="pubmed">34877261</ArticleId></ArticleIdList></Reference><Reference><Citation>Bland JM, Altman D. Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet. 1986;327(8476):307–310. doi: 10.1016/S0140-6736(86)90837-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(86)90837-8</ArticleId><ArticleId IdType="pubmed">2868172</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Cohen P, Chen S. How big is a big odds ratio? Interpreting the magnitudes of odds ratios in epidemiological studies. Commun Statis Simul Comput. 2010;39(4):860–864. doi: 10.1080/03610911003650383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03610911003650383</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr J, Cunniffe V, Kelleher P, Bernstein R, Bruce I. Successful intravenous immunoglobulin therapy in 3 cases of parvovirus B19-associated chronic fatigue syndrome. Clin Infect Dis. 2003;36(9):e100–e106. doi: 10.1086/374666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/374666</ArticleId><ArticleId IdType="pubmed">12715326</ArticleId></ArticleIdList></Reference><Reference><Citation>Barah F, Whiteside S, Batista S, Morris J. Neurological aspects of human parvovirus B19 infection: a systematic review. Rev Med Virol. 2014;24(3):154–168. doi: 10.1002/rmv.1782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1782</ArticleId><ArticleId IdType="pmc">PMC4238837</ArticleId><ArticleId IdType="pubmed">24459081</ArticleId></ArticleIdList></Reference><Reference><Citation>Evengård B, Briese T, Lindh G, Lee S, Lipkin WI. Absence of evidence of Borna disease virus infection in Swedish patients with chronic fatigue syndrome. J Neurovirol. 1999;5(5):495–499. doi: 10.3109/13550289909045378.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13550289909045378</ArticleId><ArticleId IdType="pubmed">10568886</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Xu M-M, Zeng L, Liu S, Liu X, Wang X, Li D, Huang R-Z, Zhao L-B, Zhan Q-L. Evidence for Borna disease virus infection in neuropsychiatric patients in three western China provinces. Eur J Clin Microbiol Infect Dis. 2014;33:621–627. doi: 10.1007/s10096-013-1996-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-013-1996-4</ArticleId><ArticleId IdType="pubmed">24170181</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolson G, Gan R, Haier J. Multiple co-infections (mycoplasma, chlamydia, human herpes virus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms. APMIS. 2003;111(5):557–566. doi: 10.1034/j.1600-0463.2003.1110504.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0463.2003.1110504.x</ArticleId><ArticleId IdType="pubmed">12887507</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa-Dzelzkaleja S, Krumina A, Capenko S, Nora-Krukle Z, Gravelsina S, Vilmane A, Ievina L, Shoenfeld Y, Murovska M. The persistent viral infections in the development and severity of myalgic encephalomyelitis/chronic fatigue syndrome. J Transl Med. 2023;21(1):1–12. doi: 10.1186/s12967-023-03887-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-03887-0</ArticleId><ArticleId IdType="pmc">PMC9847171</ArticleId><ArticleId IdType="pubmed">36653846</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Neal AJ, Glass KA, Emig CJ, Vitug AA, Henry SJ, Shungu DC, Mao X, Levine SM, Hanson MR. Survey of anti-pathogen antibody levels in myalgic Encephalomyelitis/Chronic fatigue syndrome. Proteomes. 2022;10(2):21. doi: 10.3390/proteomes10020021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/proteomes10020021</ArticleId><ArticleId IdType="pmc">PMC9228258</ArticleId><ArticleId IdType="pubmed">35736801</ArticleId></ArticleIdList></Reference><Reference><Citation>Aygünoğlu SK, Celebi A, Vardar N, Gürsoy E. Correlation of fatigue with depression, disability level and quality of life in patients with multiple sclerosis. Nöro Psikiyatri Arşivi. 2015;52(3):247. doi: 10.5152/npa.2015.8714.</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/npa.2015.8714</ArticleId><ArticleId IdType="pmc">PMC5353056</ArticleId><ArticleId IdType="pubmed">28360718</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent A, Benzo RP, Whipple MO, McAllister SJ, Erwin PJ, Saligan LN. Beyond pain in fibromyalgia: insights into the symptom of fatigue. Arthritis Res Ther. 2013;15(6):1–14. doi: 10.1186/ar4395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar4395</ArticleId><ArticleId IdType="pmc">PMC3978642</ArticleId><ArticleId IdType="pubmed">24289848</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammes Y, Adjriou N, Kipson N, Criado C, Charpin C, Rebaudet S, Stavris C, Guieu R, Fenouillet E, Retornaz F. Altered muscle membrane potential and redox status differentiates two subgroups of patients with chronic fatigue syndrome. J Transl Med. 2020;18(1):1–8. doi: 10.1186/s12967-020-02341-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02341-9</ArticleId><ArticleId IdType="pmc">PMC7168976</ArticleId><ArticleId IdType="pubmed">32306967</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaes AW, Van Herck M, Deng Q, Delbressine JM, Jason LA, Spruit MA. Symptom-based clusters in people with ME/CFS: an illustration of clinical variety in a cross-sectional cohort. J Transl Med. 2023;21(1):1–14. doi: 10.1186/s12967-023-03946-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-03946-6</ArticleId><ArticleId IdType="pmc">PMC9921324</ArticleId><ArticleId IdType="pubmed">36765375</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Pablos M, Paiva B, Montero-Mateo R, Garcia N, Zabaleta A. Epstein-Barr virus and the origin of myalgic encephalomyelitis or chronic fatigue syndrome. Front Immunol. 2021:4637.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8634673</ArticleId><ArticleId IdType="pubmed">34867935</ArticleId></ArticleIdList></Reference><Reference><Citation>Broderick G, Fuite J, Kreitz A, Vernon SD, Klimas N, Fletcher MA. A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun. 2010;24(7):1209–1217. doi: 10.1016/j.bbi.2010.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2010.04.012</ArticleId><ArticleId IdType="pmc">PMC2939140</ArticleId><ArticleId IdType="pubmed">20447453</ArticleId></ArticleIdList></Reference><Reference><Citation>Glassford JA. The neuroinflammatory etiopathology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Front Physiol. 2017;8:88. doi: 10.3389/fphys.2017.00088.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2017.00088</ArticleId><ArticleId IdType="pmc">PMC5314655</ArticleId><ArticleId IdType="pubmed">28261110</ArticleId></ArticleIdList></Reference><Reference><Citation>Sairenji T, Nagata K. Viral infections in chronic fatigue syndrome. Nihon rinsho Japanese J Clin Med. 2007;65(6):991–996.</Citation><ArticleIdList><ArticleId IdType="pubmed">17561687</ArticleId></ArticleIdList></Reference><Reference><Citation>Caselli E, D’Accolti M, Soffritti I, Zatelli MC, Rossi R, Degli Uberti E, Di Luca D. HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis. Virol J. 2017;14(1):1–6. doi: 10.1186/s12985-016-0672-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-016-0672-6</ArticleId><ArticleId IdType="pmc">PMC5234148</ArticleId><ArticleId IdType="pubmed">28081700</ArticleId></ArticleIdList></Reference><Reference><Citation>Murata T, Goshima F, Daikoku T, Inagaki-Ohara K, Takakuwa H, Kato K, Nishiyama Y. Mitochondrial distribution and function in herpes simplex virus-infected cells. J Gen Virol. 2000;81(2):401–406.</Citation><ArticleIdList><ArticleId IdType="pubmed">10644838</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon SD, Whistler T, Cameron B, Hickie IB, Reeves WC, Lloyd A. Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus. BMC Infect Dis. 2006;6(1):1–7. doi: 10.1186/1471-2334-6-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-6-15</ArticleId><ArticleId IdType="pmc">PMC1373655</ArticleId><ArticleId IdType="pubmed">16448567</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E-J, Son C-G. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J Transl Med. 2020;18(1):1–10. doi: 10.1186/s12967-020-02455-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02455-0</ArticleId><ArticleId IdType="pmc">PMC7391812</ArticleId><ArticleId IdType="pubmed">32727489</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>